Aposhian. 1992a. Urinary mercury after administration of 2,3-dimercaptopropane-1-sulfonic acid: Correlation with dental amalgam score. FASEB J. 6(7):2472-2476.

Aposhian, H.V., R.M. Maiorino, M. Rivera, D.C. Bruce, R.C. Dart, K.M. Hurlbut, D.J. Levine, W. Zheng, Q. Fernando, D. Carter, and M.M. Aposhian. 1992b. Human studies with the chelating agents DMPS and DMSA. Clin. Toxicol. 30(4):505-528.

Aposhian, H.V., R.M. Maiorino, D. Gonzalez-Ramirez, M. Zuniga-Charles, Z. Xu, K.M. Hurlbut, P. Junco-Munoz, R.C. Dart, and M.M. Aposhian. 1995. Mobilization of heavy metals by newer, therapeutically useful chelating agents. Toxicology 97(1-3):23-28.

Aposhian, M.M., R.M. Maiorino, Z. Xu, and H.V. Aposhian. 1996. Sodium 2,3-dimercapto-1-propanesulfaonte (DMPS) treatment does not redistribute lead or mercury to the brain of rats. Toxicology 109(1):49-55.

Arenholt-Bindslev, D., and A.H. Larsen. 1996. Mercury levels and discharge in waste water from dental clinics. Water Air Soil Pollut. 86(1-4):93-99.

Aschner, M., N.B. Eberle, and H.K. Kimelberg. 1991. Interactions of methylmercury with rat primary astrocyte cultures: Methylmercury efflux. Brain Res. 554(1-2):10-14.

Atchison, W.D., and M.F. Hare. 1994. Mechanisms of methylmercury-induced neurotoxicity. FASEB J. 8(9):622-629.

ATSDR (Agency for Toxic Substances and Disease Registry). 1999. Toxicological Profile for Mercury. (Update). U.S. Department of Health & Human Services, Agency for Toxic Substances and Disease Registry , Atlanta, GA.

Bakir, F., S.F. Damluji, L. Amin-Zaki, M. Murthadha, A. Khalidi, N.Y. Al-Rawi, S. Tikriti, H.I. Dhahir, T.W. Clarkson, J.C. Smith, and R.A. Doherty. 1973. Methylmercury poisoning in Iraq. Science 181:230-241.

Baldi, F., and M. Filippelli. 1991. New method for detecting methylmercury by its enzymic conversion to methane. Environ. Sci. Technol. 25(2):302-305.

Ballatori, N. 1991. Mechanisms of metal transport across liver cell plasma membranes. Drug Metab. Rev. 23(1-2):83-132.

Ballatori, N., and T.W. Clarkson. 1982. Developmental changes in the biliary excretion of methylmercury and glutathione. Science 216(4541):61-63.

Baron Jr, S., N. Haykal-Coates, and H.A. Tilson. 1998. Gestational exposure to methylmercury alters the developmental pattern of trk-like immuno-reactivity in the rat brain and results in cortical dysmorphology. Dev. Brain Res. 109(1):13-31.

Begley, T.P., A.E. Walts, and C.T. Walsh. 1986. Bacterial organomercurial lyase: Overproduction, isolation, and characterization . Biochemistry 25(22): 7186-7192.

Berlin, M. 1986. Mercury. Pp. 387-445 in Handbook on the Toxicology of

Front Matter (R1-R20)

Executive Summary (1-12)

Introduction (13-30)

Chemistry, Exposure, Toxicokinetics, and Toxicodynamics (31-71)

Biological Variability (72-104)

Dose Estimation (105-146)

Health Effects of Methylmercury (147-249)

Comparison of Studies for Use in Risk Assessment (250-270)

Dose-Response Assessment (271-303)

Risk Characterization and Public Health Implications (304-332)

Appendix to Chapter 7 (333-336)

Glossary (337-344)